Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 6/2008

01.06.2008 | Article

Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts

verfasst von: K. Vainio, H. H. Samdal, G. Ånestad, E. Wedege, D. H. Skutlaberg, K. T. Bransdal, R. Mundal, I. S. Aaberge

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to measure the seroprevalence to mumps in Norwegian conscripts belonging to the first children vaccination cohorts that had been offered two doses of MMR vaccine. The seroprevalence to mumps was 76% with the Microimmune assay and 85% with the Enzygnost assay. We also compared the performance of the Microimmune assay for detection of mumps- and measles-specific IgG antibodies in 340 paired serum and oral fluid samples from the conscripts and evaluated the effect of revaccination. Mumps-specific IgG antibodies were detected in only 61% of the oral fluids. In contrast, high levels of measles-specific IgG antibodies were detected in both the serum and oral fluid samples. Based on these results, we are only able to recommend the use of oral fluid for surveillance of measles in Norway. Our results may also indicate that the seroprevalence necessary to interrupt transmission of mumps has not been reached in vaccinated young adult Norwegians. Seroconversion was observed in all initially measles seronegative conscripts after revaccination, whereas 23 of 27 initially mumps seronegative conscripts failed to seroconvert.
Literatur
1.
Zurück zum Zitat Anonymous (2002) Measles and measles immunization in Norway; historical review and present situation. Eurosurveillance 6 Anonymous (2002) Measles and measles immunization in Norway; historical review and present situation. Eurosurveillance 6
3.
Zurück zum Zitat Vainio K, Samdal HH, Anestad G, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge I (2007) Seroprevalence of measles among Norwegian military conscripts in 2004. Eur J Clin Microbiol Infect Dis 26:217–220PubMedCrossRef Vainio K, Samdal HH, Anestad G, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge I (2007) Seroprevalence of measles among Norwegian military conscripts in 2004. Eur J Clin Microbiol Infect Dis 26:217–220PubMedCrossRef
4.
Zurück zum Zitat Parry JV, Perry KR, Mortimer PP (1987) Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2:72–75PubMedCrossRef Parry JV, Perry KR, Mortimer PP (1987) Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2:72–75PubMedCrossRef
5.
Zurück zum Zitat Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL (2006) Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clin Vaccine Immunol 13:764–767PubMedCrossRef Backhouse JL, Gidding HF, McIntyre PB, Gilbert GL (2006) Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clin Vaccine Immunol 13:764–767PubMedCrossRef
6.
Zurück zum Zitat Garrido RM, Blanco QA, Garrote Adrados JA, Telleria Orriols JJ, Arranz SE (1997) Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults. An Esp Pediatr 47:499–504 Garrido RM, Blanco QA, Garrote Adrados JA, Telleria Orriols JJ, Arranz SE (1997) Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults. An Esp Pediatr 47:499–504
7.
Zurück zum Zitat Gill J, Aston R, Vyse AJ, White JM, Greenwood A (2002) Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples. Commun Dis Public Health 5:314–317PubMed Gill J, Aston R, Vyse AJ, White JM, Greenwood A (2002) Susceptibility of young offenders to measles and rubella: an antibody prevalence study using oral fluid samples. Commun Dis Public Health 5:314–317PubMed
8.
Zurück zum Zitat Kremer JR, Muller CP (2005) Evaluation of commercial assay detecting specific immunoglobulin G in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 12:668–670PubMedCrossRef Kremer JR, Muller CP (2005) Evaluation of commercial assay detecting specific immunoglobulin G in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 12:668–670PubMedCrossRef
9.
Zurück zum Zitat Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT (1999) Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 83:135–144PubMedCrossRef Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT (1999) Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 83:135–144PubMedCrossRef
10.
Zurück zum Zitat Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, Cutts FT (2001) Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 79:588–595PubMed Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, Cutts FT (2001) Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 79:588–595PubMed
11.
Zurück zum Zitat Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A (1993) Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40:235–240PubMedCrossRef Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A (1993) Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 40:235–240PubMedCrossRef
12.
Zurück zum Zitat Thieme T, Piacentini S, Davidson S, Steingart K (1994) Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA 272:219–221PubMedCrossRef Thieme T, Piacentini S, Davidson S, Steingart K (1994) Determination of measles, mumps, and rubella immunization status using oral fluid samples. JAMA 272:219–221PubMedCrossRef
13.
Zurück zum Zitat Brown DW, Ramsay ME, Richards AF, Miller E (1994) Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991–3. BMJ 308:1015–1017PubMed Brown DW, Ramsay ME, Richards AF, Miller E (1994) Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991–3. BMJ 308:1015–1017PubMed
14.
Zurück zum Zitat Amela C, Pachon I, de Ory F (2003) Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 18:71–79PubMedCrossRef Amela C, Pachon I, de Ory F (2003) Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 18:71–79PubMedCrossRef
15.
16.
Zurück zum Zitat Nardone A, Pebody RG, van den Hof S, Levy-Bruhl D, Plesner AM, Rota MC, Tischer A, Andrews N, Berbers G, Crovari P, Edmunds WJ, Gabutti G, Saliou P, Miller E (2003) Sero-epidemiology of mumps in western Europe. Epidemiol Infect 131:691–701PubMedCrossRef Nardone A, Pebody RG, van den Hof S, Levy-Bruhl D, Plesner AM, Rota MC, Tischer A, Andrews N, Berbers G, Crovari P, Edmunds WJ, Gabutti G, Saliou P, Miller E (2003) Sero-epidemiology of mumps in western Europe. Epidemiol Infect 131:691–701PubMedCrossRef
17.
Zurück zum Zitat Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L (2006) Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 25:310–317PubMedCrossRef Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, Plasencia A, Salleras L (2006) Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 25:310–317PubMedCrossRef
18.
Zurück zum Zitat Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I (2006) Declining population immunity to mumps among Israeli military recruits. Vaccine 24:6300–6303PubMedCrossRef Huerta M, Davidovitch N, Aboudy Y, Ankol OE, Balicer RD, Zarka S, Grotto I (2006) Declining population immunity to mumps among Israeli military recruits. Vaccine 24:6300–6303PubMedCrossRef
19.
Zurück zum Zitat Janaszek-Seydlitz W, Bucholc B, Gorska P, Slusarczyk J (2005) Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Vaccine 23:2711–2716PubMedCrossRef Janaszek-Seydlitz W, Bucholc B, Gorska P, Slusarczyk J (2005) Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Vaccine 23:2711–2716PubMedCrossRef
20.
Zurück zum Zitat Mossong J, Putz L, Schneider F (2004) Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 132:11–18PubMedCrossRef Mossong J, Putz L, Schneider F (2004) Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 132:11–18PubMedCrossRef
21.
Zurück zum Zitat Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E (2006) Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134:1303–1312PubMedCrossRef Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E (2006) Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134:1303–1312PubMedCrossRef
22.
Zurück zum Zitat Gay NJ, Vyse AJ, Enquselassie F, Nigatu W, Nokes DJ (2003) Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 130:285–291PubMedCrossRef Gay NJ, Vyse AJ, Enquselassie F, Nigatu W, Nokes DJ (2003) Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 130:285–291PubMedCrossRef
23.
Zurück zum Zitat Madar R, Straka S, Baska T (2002) Detection of antibodies in saliva—an effective auxiliary method in surveillance of infectious diseases. Bratisl Lek Listy 103:38–41PubMed Madar R, Straka S, Baska T (2002) Detection of antibodies in saliva—an effective auxiliary method in surveillance of infectious diseases. Bratisl Lek Listy 103:38–41PubMed
24.
Zurück zum Zitat Nigatu W, Nokes DJ, Afework A, Brown DW, Cutts FT, Jin L (2006) Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000–2004. J Med Virol 78:1648–1655PubMedCrossRef Nigatu W, Nokes DJ, Afework A, Brown DW, Cutts FT, Jin L (2006) Serological and molecular epidemiology of measles virus outbreaks reported in Ethiopia during 2000–2004. J Med Virol 78:1648–1655PubMedCrossRef
Metadaten
Titel
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts
verfasst von
K. Vainio
H. H. Samdal
G. Ånestad
E. Wedege
D. H. Skutlaberg
K. T. Bransdal
R. Mundal
I. S. Aaberge
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0460-3

Weitere Artikel der Ausgabe 6/2008

European Journal of Clinical Microbiology & Infectious Diseases 6/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.